ChemoCentryx Funding & Investors
ChemoCentryx, Inc. operates as a biopharmaceutical company. The Company researches orally-administered small-molecule therapies for inflammatory diseases.
chemocentryx.comTotal Amount Raised: $634,339,968
ChemoCentryx Funding Rounds
Series E
$50,000,000
Series E Investors
Glaxo GroupHealthCapHBM Healthcare InvestmentsAlta PartnersSeries D
$29,840,000
Series D Investors
Glaxo GroupAlta PartnersHBM Healthcare InvestmentsGimvOrbiMed AdvisorsSeries C
$17,700,000
Series C Investors
OrbiMed AdvisorsGimvAlta PartnersJennison AssociatesHBM Healthcare InvestmentsBio-TechneSeries B
$33,000,000
Series B Investors
Alta PartnersHBM Healthcare InvestmentsGimvOrbiMed AdvisorsHealthCapPost Ipo Equity
$64,400,000
Post Ipo Equity
$325,400,000
Post Ipo Debt
$100,000,000
Post Ipo Debt Investors
Hercules CapitalPost Ipo Equity
$325,400,000
Post Ipo Debt
$100,000,000
Post Ipo Debt Investors
Hercules CapitalGrant
$14,000,000
Funding info provided by Diffbot.